SOD1 and plasma cell myeloma: Some reports indicated that myeloma and lymphoma patients undergoing ASCT displayed heightened oxidative activity, measured by malondialdehyde (MDA), a lipid peroxidation product, and catalase (CAT) and superoxide dismutase (SOD) enzymes along with a high DNA damage index, in comparison to the control group.